HK1013623A1 - Aqueous concentrated solutions containing argatroban - Google Patents

Aqueous concentrated solutions containing argatroban

Info

Publication number
HK1013623A1
HK1013623A1 HK98114973A HK98114973A HK1013623A1 HK 1013623 A1 HK1013623 A1 HK 1013623A1 HK 98114973 A HK98114973 A HK 98114973A HK 98114973 A HK98114973 A HK 98114973A HK 1013623 A1 HK1013623 A1 HK 1013623A1
Authority
HK
Hong Kong
Prior art keywords
solutions containing
concentrated solutions
aqueous concentrated
argatroban
esp
Prior art date
Application number
HK98114973A
Other languages
English (en)
Inventor
Frederic Andre
Veronique Avril
Jean Montel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of HK1013623A1 publication Critical patent/HK1013623A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
HK98114973A 1994-02-03 1998-12-23 Aqueous concentrated solutions containing argatroban HK1013623A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401195A FR2715566B1 (fr) 1994-02-03 1994-02-03 Solutions aqueuses concentrées d'argatroban.

Publications (1)

Publication Number Publication Date
HK1013623A1 true HK1013623A1 (en) 1999-09-03

Family

ID=9459714

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114973A HK1013623A1 (en) 1994-02-03 1998-12-23 Aqueous concentrated solutions containing argatroban

Country Status (25)

Country Link
US (1) US5679690A (ru)
EP (1) EP0669131B1 (ru)
JP (1) JP3027103B2 (ru)
KR (1) KR100257692B1 (ru)
CN (1) CN1054743C (ru)
AT (1) ATE179327T1 (ru)
AU (1) AU687133B2 (ru)
CA (1) CA2141704C (ru)
CZ (1) CZ284611B6 (ru)
DE (1) DE69509279T2 (ru)
DK (1) DK0669131T3 (ru)
ES (1) ES2132547T3 (ru)
FI (1) FI950459A (ru)
FR (1) FR2715566B1 (ru)
GR (1) GR3030149T3 (ru)
HK (1) HK1013623A1 (ru)
HU (1) HU218220B (ru)
IL (1) IL112527A (ru)
NO (1) NO307324B1 (ru)
NZ (1) NZ270445A (ru)
PL (1) PL178586B1 (ru)
RU (1) RU2136282C1 (ru)
SK (1) SK12795A3 (ru)
TW (1) TW436295B (ru)
ZA (1) ZA95837B (ru)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5786153A (en) * 1996-09-12 1998-07-28 Chiron Diagnostics Corporation Prevention of probe coating on automated analyzers using a non-denaturing surfactant
CA2291735A1 (en) * 1997-05-27 1998-12-03 Takahiro Ogawa Israpafant-containing water-base preparations
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
FR2793412B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'argatroban pour administration sous-cutanee
KR100399373B1 (ko) * 2000-12-20 2003-09-26 주식회사 아이센스 콜란산 고리를 포함하는 디글라이콜릭 디아마이드 유도체,그의 제조방법 및 용도
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
AU2002309528A1 (en) 2001-04-02 2002-10-15 Therasense, Inc. Blood glucose tracking apparatus and methods
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
KR101010547B1 (ko) * 2003-03-20 2011-01-24 미쓰비시 타나베 파마 코퍼레이션 알기닌아미드류를 함유하는 의약 제제
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
RU2416393C2 (ru) * 2005-09-01 2011-04-20 Бакстер Интернэшнл Инк. Препаративная форма аргатробана
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
JP5577094B2 (ja) * 2006-08-31 2014-08-20 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための化合物及び組成物
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
JP5624766B2 (ja) * 2006-09-27 2014-11-12 イーグル・ファーマシューティカルズ・インコーポレーテッド アルコールを含まないアルガトロバン製剤
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US9724362B2 (en) 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc ANALYTICAL SIGNAL PROCESSING APPARATUS AND METHOD
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc ANALYTICAL SUBSTANCE MONITORING SYSTEM AND METHODS OF MANAGING ENERGY AND NOISE
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
CN102366410B (zh) * 2011-09-14 2013-05-29 海南灵康制药有限公司 一种阿加曲班脂质体注射剂
EP2775918B1 (en) 2011-11-07 2020-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2015006679A2 (en) 2013-07-11 2015-01-15 Aqua Turf International, Inc. Air filtration mask with opening front cover
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
CN114025746B (zh) * 2019-05-10 2023-08-25 福多兹制药公司 抗血栓形成剂的可注射聚合物纳米颗粒组合物及其方法
CN110478471B (zh) * 2019-09-17 2020-04-10 鲁南制药集团股份有限公司 一种阿加曲班注射液及其制备方法
KR20220145892A (ko) 2020-07-03 2022-10-31 도시바 미쓰비시덴키 산교시스템 가부시키가이샤 무정전 전원 시스템
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
CN113855635A (zh) * 2021-10-20 2021-12-31 陇南市第一人民医院 一种阿加曲班注射液脂质体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
JPH02129123A (ja) * 1988-11-07 1990-05-17 Mitsubishi Kasei Corp 抗血液凝固剤
CA2091715A1 (en) * 1992-03-18 1993-09-19 Mitsubishi Kasei Corporation Argatroban preparations for ophthalmic use
EP0566897A3 (en) * 1992-04-07 1994-07-06 Hoechst Ag The complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use

Also Published As

Publication number Publication date
DK0669131T3 (da) 1999-11-01
RU95101387A (ru) 1997-02-27
EP0669131B1 (fr) 1999-04-28
KR100257692B1 (ko) 2000-08-01
IL112527A0 (en) 1995-05-26
ATE179327T1 (de) 1999-05-15
FR2715566B1 (fr) 1996-03-08
NO307324B1 (no) 2000-03-20
NO950377D0 (no) 1995-02-02
CZ27195A3 (en) 1995-09-13
JPH07277980A (ja) 1995-10-24
FI950459A0 (fi) 1995-02-02
RU2136282C1 (ru) 1999-09-10
PL307041A1 (en) 1995-08-07
DE69509279T2 (de) 1999-11-25
JP3027103B2 (ja) 2000-03-27
CA2141704C (fr) 2001-07-03
FR2715566A1 (fr) 1995-08-04
DE69509279D1 (de) 1999-06-02
CN1109754A (zh) 1995-10-11
CA2141704A1 (fr) 1995-08-04
CZ284611B6 (cs) 1999-01-13
IL112527A (en) 1999-04-11
ES2132547T3 (es) 1999-08-16
HU218220B (hu) 2000-06-28
US5679690A (en) 1997-10-21
CN1054743C (zh) 2000-07-26
SK12795A3 (en) 1995-08-09
EP0669131A1 (fr) 1995-08-30
GR3030149T3 (en) 1999-08-31
AU687133B2 (en) 1998-02-19
FI950459A (fi) 1995-08-04
HUT71524A (en) 1995-12-28
NO950377L (no) 1995-08-04
AU1154395A (en) 1995-08-10
KR950031042A (ko) 1995-12-18
NZ270445A (en) 1995-07-26
TW436295B (en) 2001-05-28
ZA95837B (en) 1996-03-29
PL178586B1 (pl) 2000-05-31

Similar Documents

Publication Publication Date Title
HK1013623A1 (en) Aqueous concentrated solutions containing argatroban
NZ278072A (en) Phenylacetic acid oxime derivatives; biocides
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
HK1010365A1 (en) A method for the preparation of aqueous solutions containing performic acid as well as their use
MY113733A (en) Salts of an anti-migraine indole derivative
ES2190429T3 (es) Benciliden-quinuclidinonas como agentes protectores contra el sol.
HU9402356D0 (en) Pharmaceutical compositions
PL308203A1 (en) Synthesis of n-acetloneuraminic acid derivatives
CA2209764A1 (fr) Procede de fabrication de solutions aqueuses de sels d'ammonium quaternaire insatures
DE59808253D1 (de) Haarbehandlungsmittel
BG99197A (en) Means for the treatment of cataract and method for its preparation
NO964627D0 (no) Fremgangsmåte for fremstilling av 4-amino-4-3-ketosteroider fra 4-nitro-4-3-ketosteroider
EP0319073A3 (en) Cyclo-octane neuroprotective agents
AP9400608A0 (en) "New nicotinic acid derivative".
ES2059275A1 (es) Un procedimiento para producir derivados de acidos grasos halogenofenoxi-sustituidos.
HUP9904595A2 (hu) Továbbfejlesztett diagnosztikai és terápiás készítmények

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040202

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)